Significance of Diabetic Kidney Disease Biomarkers in Predicting Metabolic-Associated Fatty Liver Disease

被引：3
作者：
Bae, Jaehyun [1 ]
Lee, Byung-Wan [2 ]
机构：
[1] Catholic Kwandong Univ, Int St Marys Hosp, Dept Internal Med, Div Endocrinol & Metab,Coll Med, Int St, Incheon 22711, South Korea
[2] Yonsei Univ, Dept Internal Med, Div Endocrinol & Metab, Coll Med, Seoul 03722, South Korea
来源：
BIOMEDICINES | 2023年 / 11卷 / 07期
关键词：
diabetic kidney disease; metabolic-associated fatty liver disease; biomarker; GELATINASE-ASSOCIATED LIPOCALIN; ACID-BINDING PROTEIN; SERUM CYSTATIN C; INSULIN-RESISTANCE; PROXIMAL TUBULE; THERAPEUTIC TARGETS; RENAL DYSFUNCTION; MOLECULE-1; KIM-1; URINARY ENZYMES; FETUIN-A;
D O I：
10.3390/biomedicines11071928
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Metabolic-associated fatty liver disease (MAFLD) and diabetic kidney disease (DKD) share various pathophysiological factors, and epidemiological evidence suggests that these two diseases are associated. Albuminuria and the estimated glomerular filtration rate, which are conventional biomarkers of DKD, are reportedly associated with the risk or severity of MAFLD. Recently, novel DKD biomarkers reflecting renal tubular injury have been introduced to complement conventional DKD markers. In this article, we looked at previous studies that showed an association between MAFLD and DKD, and also reviewed the significance of DKD biomarkers as predictive risk factors for MAFLD.
引用
收藏
页数：13
相关论文
共 50 条
  • [41] Metabolic-Associated Fatty Liver Disease Is Highly Prevalent in the Postacute COVID Syndrome
    Milic, Jovana
    Barbieri, Sara
    Gozzi, Licia
    Brigo, Alberto
    Beghe, Bianca
    Verduri, Alessia
    Bacca, Erica
    Iadisernia, Vittorio
    Cuomo, Gianluca
    Dolci, Giovanni
    Yaacoub, Dina
    Aprile, Emanuele
    Belli, Michela
    Venuta, Maria
    Meschiari, Marianna
    Sebastiani, Giada
    Clini, Enrico
    Mussini, Cristina
    Lonardo, Amedeo
    Guaraldi, Giovanni
    Raggi, Paolo
    OPEN FORUM INFECTIOUS DISEASES, 2022, 9 (03):
  • [42] The prevalence of metabolic-associated fatty liver disease in the Turkish population: A multicenter study
    Yilmaz, Yusuf
    Yilmaz, Nimet
    Ates, Fehmi
    Karakaya, Fatih
    Gokcan, Hale
    Kaya, Eda
    Adali, Gupse
    Kartal, Aysun Caliskan
    Sen, Ilker
    Ahishali, Emel
    Ozenirler, Seren
    Koruk, Mehmet
    Uygun, Ahmet
    Idilman, Ramazan
    HEPATOLOGY FORUM, 2021, 2 (02): : 37 - 42
  • [43] Distinctive gut microbial dysbiosis between chronic alcoholic fatty liver disease and metabolic-associated fatty liver disease in mice
    Kang, Kai
    Sun, Yue
    Pan, Dan
    Sang, Li-Xuan
    Sun, Ming-Jun
    Li, Yi-Ling
    Chang, Bing
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2021, 21 (05)
  • [44] Risk factors and cardio-metabolic outcomes associated with metabolic-associated fatty liver disease in childhood
    de Groot, Jasmin
    Santos, Susana
    Geurtsen, Madelon L.
    Felix, Janine F.
    Jaddoe, Vincent W. V.
    ECLINICALMEDICINE, 2023, 65
  • [45] Nonalcoholic fatty liver disease without overlapping metabolic-associated fatty liver disease and the risk of incident type 2 diabetes
    Cho, Yoosun
    Chang, Yoosoo
    Ryu, Seungho
    Wild, Sarah H.
    Byrne, Christopher D.
    LIVER INTERNATIONAL, 2023, 43 (11) : 2445 - 2454
  • [46] Review of current and new drugs for the treatment of metabolic-associated fatty liver disease
    Gish, Robert
    Fan, Jian-Gao
    Dossaji, Zahra
    Fichez, Jeanne
    Laeeq, Tooba
    Chun, Magnus
    Boursier, Jerome
    HEPATOLOGY INTERNATIONAL, 2024, 18 (SUPPL 2) : 977 - 989
  • [47] Validation of Non-invasive Fibrosis Scores for Predicting Advanced Fibrosis in Metabolic-associated Fatty Liver Disease
    Chen, Xiaoning
    Goh, George Boon-Bee
    Huang, Jiaofeng
    Wu, Yinlian
    Wang, Mingfang
    Kumar, Rahul
    Lin, Su
    Zhu, Yueyong
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2022, 10 (04) : 589 - 594
  • [48] Biological targets of berberine hydrochloride and the mechanisms by which it alleviates metabolic-associated fatty liver disease
    Liang, Jingjia
    Gu, Aihua
    CHINESE SCIENCE BULLETIN-CHINESE, 2023, 68 (05): : 469 - 478
  • [49] Unveiling the Role of the Fatty Acid Binding Protein 4 in the Metabolic-Associated Fatty Liver Disease
    Moreno-Vedia, Juan
    Girona, Josefa
    Ibarretxe, Daiana
    Masana, Lluis
    Rodriguez-Calvo, Ricardo
    BIOMEDICINES, 2022, 10 (01)
  • [50] Metabolic-associated fatty liver disease is associated with low muscle mass and strength in patients with chronic hepatitis B
    Santos, Cecy Maria de Lima
    Brito, Matheus Duarte
    de Castro, Pedro Alves Soares Vaz
    de Vries, Thais Pontello
    Viana, Nataly Lopes
    Coelho, Marta Paula Pereira
    Malheiro, Olivio Brito
    Bering, Tatiana
    Gonzalez, Maria Cristina
    Teixeira, Rosangela
    Cambraia, Rodrigo Dias
    Rocha, Gifone Aguiar
    Silva, Luciana Diniz
    WORLD JOURNAL OF HEPATOLOGY, 2022, 14 (08) : 1652 - 1666
12345